Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03371212 · ClinicalTrials.gov registry record · Phase 4
A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA
A Phase 4 study of Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium, sponsored by Rush University Medical Center.
- Active
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT03371212 is a Phase 4 study of Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 52 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03371212, a Phase 4 study of Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium, is active but no longer recruiting, sponsored by Rush University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if the use of a modular dual mobility bearing is associated with clinically important increases in serum metal levels.
Conditions Studied
Interventions
- DEVICE Dual mobility cohort
- DEVICE Conventional cohort
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2036-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03371212
The ClinicalTrials.gov registry entry for NCT03371212 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium appearing as the primary indexed condition, and to 2 interventions - of which Dual mobility cohort is the first listed.
NCT03371212 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03371212 about?
NCT03371212 is a clinical study titled "A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA". The aim of this study is to determine if the use of a modular dual mobility bearing is associated with clinically important increases in serum metal levels.
What is the current status of trial NCT03371212?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2017-12-15. Estimated completion is 2036-12-01.
What conditions does trial NCT03371212 study?
This clinical trial studies the following conditions: Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium.
What interventions are being tested in trial NCT03371212?
The interventions under investigation include: Dual mobility cohort (DEVICE), Conventional cohort (DEVICE).
Who is sponsoring clinical trial NCT03371212?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03371212 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.